CPIVC NEWS

AIM's iterative process high-efficiency diploid rabies vaccine completes Phase III trials, efficacy significantly higher than existing market products

2026-06-01

Link: https://www.prnewswire.com/apac/news-releases/aims-iterative-process-high-efficiency-diploid-rabies-vaccine-completes-phase-iii-clinical-trials-efficacy-significantly-higher-than-existing-market-products-302661364.html